Targeting raised von Willebrand factor levels and macrophage activation in severe COVID-19: Consider low volume plasma exchange and low dose steroid
| Autor: | Ashish Goel, K.A. Balasubramanian, Sukesh Chandran Nair, I. J. Mackie, Elwyn Elias, CE Eapen, Uday Zachariah |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
2019-20 coronavirus outbreak Coronavirus disease 2019 (COVID-19) medicine.medical_treatment Pneumonia Viral Infections Article Steroid Betacoronavirus Von Willebrand factor Internal medicine von Willebrand Factor medicine Humans Macrophage Pandemics Factor VIII Plasma Exchange biology SARS-CoV-2 business.industry Low dose COVID-19 Hematology Macrophage Activation Low volume von Willebrand Diseases Endocrinology biology.protein Coronavirus Infections business |
| Zdroj: | Thrombosis Research |
| ISSN: | 0049-3848 |
| DOI: | 10.1016/j.thromres.2020.05.001 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect